Secondary Hormonal Therapy in Men With Castration
... percentages for categorical variables and median and range for continuous variables. Duration of primary ADT was defined as the time between the date of first luteinizing hormone-releasing hormone (LHRH) agonist/antagonist or orchiectomy and the start date of first secondary HT. We defined the date ...
... percentages for categorical variables and median and range for continuous variables. Duration of primary ADT was defined as the time between the date of first luteinizing hormone-releasing hormone (LHRH) agonist/antagonist or orchiectomy and the start date of first secondary HT. We defined the date ...
NIH Public Access - Ciencia que se respira
... The NHIS questionnaire has certain limitations: it does not record the age of the relative at diagnosis or ask the respondent to list the cancer within the relative with site-specific prompting as to cancer type. In addition, family history reporting is subject to bias, influenced by respondent’s re ...
... The NHIS questionnaire has certain limitations: it does not record the age of the relative at diagnosis or ask the respondent to list the cancer within the relative with site-specific prompting as to cancer type. In addition, family history reporting is subject to bias, influenced by respondent’s re ...
Integrative molecular concept modeling of
... an independent sample set (Supplementary Fig. 2 online). We validated the overexpression of two transcripts, ZIC2 (which is involved in the hedgehog signaling pathway30) and a noncoding transcript at 11q13.1 (a region in which amplification predicts progression to metastatic disease31), as described ...
... an independent sample set (Supplementary Fig. 2 online). We validated the overexpression of two transcripts, ZIC2 (which is involved in the hedgehog signaling pathway30) and a noncoding transcript at 11q13.1 (a region in which amplification predicts progression to metastatic disease31), as described ...
DOCX - Consumer Involvement Toolkit
... Cancer Council Northern Territory The Cancer Council NT is a not-for-profit organisation working to reduce the impact of cancer on people living in the Northern Territory. http://www.cancercouncilnt.com.au/ Cancer Council ACT Cancer Council ACT is a not-for-profit community organisation that aims to ...
... Cancer Council Northern Territory The Cancer Council NT is a not-for-profit organisation working to reduce the impact of cancer on people living in the Northern Territory. http://www.cancercouncilnt.com.au/ Cancer Council ACT Cancer Council ACT is a not-for-profit community organisation that aims to ...
Cancer Rethinking Screening for Breast Cancer and Prostate
... Screening with a focus on high sensitivity will increase cancer detection rates, which has been demonstrated for other cancersinthesettingofpopulation-based screening, including neuroblastoma22,23 and now likely lung cancer with the introduction of computed tomographic (CT)–based screening.24 Early ...
... Screening with a focus on high sensitivity will increase cancer detection rates, which has been demonstrated for other cancersinthesettingofpopulation-based screening, including neuroblastoma22,23 and now likely lung cancer with the introduction of computed tomographic (CT)–based screening.24 Early ...
Cancer Registry project - CM
... public use. Cancer is monitored, patterns of cancer in different groups of people, cancer control programs, research, and provides information of cancer for a national data base. Information on all cancer cases in Maine are collected for The CDC Maine Cancer registry. The Cancer Registry contains re ...
... public use. Cancer is monitored, patterns of cancer in different groups of people, cancer control programs, research, and provides information of cancer for a national data base. Information on all cancer cases in Maine are collected for The CDC Maine Cancer registry. The Cancer Registry contains re ...
- Wiley Online Library
... (mitoxantrone vs. docetaxel), serial PSA and serum CLU assessments, and survival. PSA and CLU were defined as biomarkers. Each subject’s serial biomarker measurements through 1 year were fit to a quadratic model, and the estimated model in its functional form was used as a source of subject-specific ...
... (mitoxantrone vs. docetaxel), serial PSA and serum CLU assessments, and survival. PSA and CLU were defined as biomarkers. Each subject’s serial biomarker measurements through 1 year were fit to a quadratic model, and the estimated model in its functional form was used as a source of subject-specific ...
or Triptorelin (Decapeptyl SR) in the treatment of prostate
... Leuprorelin – Hepatic dysfunction and jaundice with elevated liver enzyme reported. Close observation recommended and appropriate measures taken if necessary. Usual response time : Response itself is variable and will be monitored by secondary care. Response time in those that do respond is also var ...
... Leuprorelin – Hepatic dysfunction and jaundice with elevated liver enzyme reported. Close observation recommended and appropriate measures taken if necessary. Usual response time : Response itself is variable and will be monitored by secondary care. Response time in those that do respond is also var ...
Radionuclide Therapies in Prostate Cancer: Integrating Radium
... (1.35 μCi) per kilogram of body weight, administered intravenously at 4-week intervals [10, 11, 20, 21, 38–40]. Radium-223 represents an important advancement, as the only radiopharmaceutical agent that improves OS in mCRPC patients. ...
... (1.35 μCi) per kilogram of body weight, administered intravenously at 4-week intervals [10, 11, 20, 21, 38–40]. Radium-223 represents an important advancement, as the only radiopharmaceutical agent that improves OS in mCRPC patients. ...
Expectant Management for Men With Early Stage Prostate Cancer
... established in the 1960s47 and modified in 2005,48 has been shown to predict biochemical free survival after radical prostatectomy.49,50 Clinical staging of prostate cancer— based on digital rectal examination—is less reliable in predicting pathologic stage and risk of biochemical progression after ...
... established in the 1960s47 and modified in 2005,48 has been shown to predict biochemical free survival after radical prostatectomy.49,50 Clinical staging of prostate cancer— based on digital rectal examination—is less reliable in predicting pathologic stage and risk of biochemical progression after ...
here
... This is an experimental form of treatment that is not standard practice. Your doctors will discuss other options with you in detail so that you can make a decision about whether to take part in this clinical trial. The prostate will be treated with a new technology called High Intensity Focused Ultr ...
... This is an experimental form of treatment that is not standard practice. Your doctors will discuss other options with you in detail so that you can make a decision about whether to take part in this clinical trial. The prostate will be treated with a new technology called High Intensity Focused Ultr ...
What is the purpose of bowel cancer screening?
... screening. They will be invited for bowel cancer screening every two years if still within the eligible age range for routine screening. Remember, if you are over 70 you can request a kit by calling the helpline 0800 707 6060. Around 2 in 100 people will receive an abnormal result. They will be refe ...
... screening. They will be invited for bowel cancer screening every two years if still within the eligible age range for routine screening. Remember, if you are over 70 you can request a kit by calling the helpline 0800 707 6060. Around 2 in 100 people will receive an abnormal result. They will be refe ...
stampede: patient information sheet-general
... reduce the level of testosterone in the body. This is achieved by using a range of drugs which reduce the signals to the testicles so they do not make the hormone, or by surgically removing the part of the testicles that produces testosterone. Some men may also have radiotherapy as part of their sta ...
... reduce the level of testosterone in the body. This is achieved by using a range of drugs which reduce the signals to the testicles so they do not make the hormone, or by surgically removing the part of the testicles that produces testosterone. Some men may also have radiotherapy as part of their sta ...
US Preventive Services Task Force Updates
... Colorectal cancer is the second leading cause of cancer death in the United States. In 2016, an estimated 134,000 persons will be diagnosed with the disease, and about 49,000 will die from it. To update its 2008 recommendation, the USPSTF reviewed the evidence on the effectiveness of several screeni ...
... Colorectal cancer is the second leading cause of cancer death in the United States. In 2016, an estimated 134,000 persons will be diagnosed with the disease, and about 49,000 will die from it. To update its 2008 recommendation, the USPSTF reviewed the evidence on the effectiveness of several screeni ...
PDF-3.9M - ScienceCentral
... LNCaP prostate cancer cells and enhance dihydrotestosterone (DHT)-induced AR transcriptional activity, resulting in increased expression of prostate-specific antigen (PSA) and kallikrein-related peptidase 2 (KLK2). Interestingly, among the previously reported SCD-derived peptides produced by proteol ...
... LNCaP prostate cancer cells and enhance dihydrotestosterone (DHT)-induced AR transcriptional activity, resulting in increased expression of prostate-specific antigen (PSA) and kallikrein-related peptidase 2 (KLK2). Interestingly, among the previously reported SCD-derived peptides produced by proteol ...
Lee Memorial Health System Regional Cancer Center Annual
... Gyn-Oncologist serving as an advisory editor for the 8th AJCC Manual for Staging. Regional Breast Center Surgeons in conjunction with Sanctuary outpatient services completed a poster presentation on outpatient mastectomy and opoid sparing anesthesia. Cancer Registrar had quality improvement study ac ...
... Gyn-Oncologist serving as an advisory editor for the 8th AJCC Manual for Staging. Regional Breast Center Surgeons in conjunction with Sanctuary outpatient services completed a poster presentation on outpatient mastectomy and opoid sparing anesthesia. Cancer Registrar had quality improvement study ac ...
Evaluation of Serum Protein Profiling by Surface
... protein profiles may have clinical utility as a diagnostic tool for the early detection of prostate cancer, including prostatic adenocarcinoma (PCa) (6, 8 ). Specifically, using just nine differentially expressed protein peaks, the assay achieved an overall PCa case/control correct classification ra ...
... protein profiles may have clinical utility as a diagnostic tool for the early detection of prostate cancer, including prostatic adenocarcinoma (PCa) (6, 8 ). Specifically, using just nine differentially expressed protein peaks, the assay achieved an overall PCa case/control correct classification ra ...